FDA approves Watson Pharmaceuticals' generic version of VALTREX tablets

Links shared publicly online about this topic.

  • 1,143
    total visits

FDA approves Watson Pharmaceuticals' generic version of VALTREX tablets

news-medical.net

Watson Pharmaceuticals, Inc., today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration on its Abbreviated New Drug Application for Valacyclovir Hydrochloride tablets, USP, in the 500 and 1000 mg strengths, the generic equivalent to GlaxoSmithKline, LLC's VALTREX tablets.

View full resource at news-medical.net

Tags: Herpes Medication, Drug, Pharma, Health Insurance, Medicare, FDA, Valtrex, Watson Pharmaceuticals

  • Share

Most Recently Shared on May 25, 2010 at 9:13 am By:

Medicare_News News-Medical.Net

Medicare News: FDA approves Watson Pharmaceuticals' generic version of VALTREX tablets: Watson Pharmaceuticals, In... http://bit.ly/dpMoM5

2 years ago...

Watson seeks FDA approval to market generic version of Pfizer's Viagra

news-medical.net — “Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Sildenafil Citrate Tablets, 25, 50 and 100 mg. Watson's Sildenafil Citrate tablets are a generic version of Pfizer Inc.'s Viagra®, which is indicated for the treatment of erectile dysfunction (ED).View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on June 3, 2011 at 12:47 pm By:

NewsMedical News-Medical.Net Health News

Watson seeks FDA approval to market generic version of Pfizer's Viagra: Watson Pharmaceuticals, Inc. today confi... http://bit.ly/jEYgoE

12 months ago...

Watson, Natco confirm development agreement for generic Revlimid

news-medical.net — “Watson Pharmaceuticals, Inc. and Natco Pharma Limited today confirmed an exclusive, U.S. development and license agreement, to develop and commercialize lenalidomide 5, 10, 15 and 25 mg tablets. The companies also confirmed that Natco has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its lenalidomide 5, 10, 15 and 25 mg product. Natco's lenalidomide tablets are generic versions of Celgene's Revlimid ® Tablets.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on December 7, 2010 at 3:34 pm By:

Oncology_News News-Medical.Net Health News and Oncology

Oncology News: Watson, Natco confirm development agreement for generic Revlimid: Watson Pharmaceuticals, Inc. an... http://bit.ly/gdcLq8

1 year ago...

Teva Pharmaceutical Industries launches generic Valtrex

news-medical.net — “Teva Pharmaceutical Industries Ltd. today announced U.S. Food and Drug Administration (FDA) approval and commercial launch of its generic version of GlaxoSmithKline's antiviral product, Valtrex® (valacyclovir hydrochloride) Tablets 500 mg and 1 g.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on May 25, 2010 at 2:36 pm By:

NewsMedical News-Medical.Net Health News

Teva Pharmaceutical Industries launches generic Valtrex: Teva Pharmaceutical Industries Ltd. today announced U.S. ... http://bit.ly/afQcLg

2 years ago...

Advertisement